Corcept Therapeutics to Announce Third Quarter 2013 Financial Results and Host Conference Call
November 04 2013 - 5:00PM
Marketwired
Corcept Therapeutics to Announce Third Quarter 2013 Financial
Results and Host Conference Call
MENLO PARK, CA--(Marketwired - Nov 4, 2013) - Corcept
Therapeutics Incorporated (NASDAQ: CORT) today announced it will
report third quarter 2013 financial results on November 7, 2013.
The Company will host a conference call that day at 5:00 p.m.
Eastern Time (2:00 p.m. Pacific Time).
Conference Call Information
To participate, dial 1-888-771-4371 from the United States or
+1-847-585-4405 internationally approximately 10 minutes before the
start of the call. The passcode is 35967600.
A replay will be available through November 21, 2013 at
1-888-843-7419 from the United States and +1-630-652-3042
internationally. The passcode is 35967600.
About Corcept Therapeutics Incorporated
Corcept is a pharmaceutical company engaged in the discovery,
development and commercialization of drugs for the treatment of
severe metabolic and psychiatric disorders. Korlym, a first
generation competitive GR-II antagonist, is the company's first
FDA-approved medication. The company has a phase 3 trial underway
for mifepristone for treatment of the psychotic features of
psychotic depression and a portfolio of selective GR-II antagonists
that competitively block the effects of cortisol but not
progesterone. It owns extensive intellectual property covering the
use of GR-II antagonists, including mifepristone, in the treatment
of a wide variety of metabolic, psychiatric and other
disorders. It also holds composition of matter patents for its
selective GR-II antagonists.
CONTACT: Charles Robb Chief Financial Officer Corcept
Therapeutics 650-688-8783 Email Contact www.corcept.com
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Sep 2023 to Sep 2024